Of course, individual experiences during Semaglutide GLP-1 treatment vary, so its important to remember that everyones body responds differently
Results Animals and food intake At the start of the study, mean body weight of the animals was 243 g
Phase 1a: First-in-Human Single Ascending Dose Study (NCT02951806) Study Title: "Safety, Tolerability, and Pharmacokinetics of Single Doses of Cagrilintide in Healthy Subjects" Status: Completed Phase: Phase 1a Enrollment: 48 healthy volunteers Study Period: 2016-2017 Location: Single center (Denmark) Design: Randomized, double-blind, placebo-controlled, single ascending dose Dose Range: 0.03-10 mg SC Primary Endpoints: Safety, tolerability, PK parameters Population: Healthy male subjects, BMI 20-28 Key Results: Pharmacokinetics: Terminal half-life 5-7 days across dose range
Rachelle C
But what happens after people who use them reach their goal weight
Biochem Biophys Res Commun 2005;333(2):404-410